| Biotechnology Industry | Healthcare Sector | - CEO | TWSE Exchange | TW0003164000 ISIN |
| Taiwan Country | - Employees | 8 Apr 2026 Last Dividend | 4 Sep 2014 Last Split | - IPO Date |
GenMont Biotech Incorporation, established in 2000, operates from its headquarters in Tainan City, Taiwan, focusing on the research, development, manufacture, and sale of functional probiotic supplements. The company has carved a niche for itself in Taiwan's biotech industry by specializing in probiotic solutions designed for various health-related applications, ensuring a broad market appeal. Throughout its operational history spanning over two decades, GenMont Biotech has committed itself to advancing health and wellness through innovative biotechnological research and product development.